Emsam

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2015
0120032015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Selegiline (L-deprenyl) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) at the conventional dose (10 mg/day… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2010
2010
BACKGROUND Although ongoing cohort studies offer a unique opportunity to apply existing information collected prospectively to… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2008
Review
2008
212 P&T® • April 2008 • Vol. 33 No. 4 ABSTRACT Although monoamine oxidase inhib itors (MAOIs) at one time represented the… (More)
  • table 1
  • table 3
Is this relevant?
2007
2007
We investigated the use of EMSAM in the first year post-launch in the US-April of 2006 through March of 2007. According to our… (More)
Is this relevant?
2007
2007
Non-selective inhibition of monoamine oxidase (MAO) enzymes (ie, isoforms A and B) in the brain are associated with clinically… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2006
2006
  • The Medical letter on drugs and therapeutics
  • 2006
 
Is this relevant?
Review
2003
Review
2003
  • Drugs in R&D
  • 2003
 
Is this relevant?